SpringWorks Therapeutics, Inc.

SWTXNASDAQHealthcare

$46.99

+$0.01(+0.02%)

Market Cap$3.5B

P/E Ratio—

52W High$62

52W Low$28.21

Avg Volume5.6M

Open$46.99

Beta0.70

Cash on Hand Financials Revenue

SpringWorks Therapeutics, Inc. (SWTX) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

SWTX · cash on hand · updated Dec 31, 2024

Core cash position

as of Dec 31, 2024

Cash & Short-Term Investments (CCE + ST Investments)

$308.0M▼ -35.7% vs prior year

FY · as of Dec 31, 2024 · Reported in USD

Cash & Cash Equiv. (CCE)

$69.8M

cashAndCashEquivalents

Short-Term Investments

$238.2M

shortTermInvestments

YoY Change vs Prior Year

-35.7%

vs prior fiscal year

Latest Quarter

$287.9M

Q1 2025

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2024

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$308.0MCash on Hand

Total Debt$7.9MTotal Debt

Net Cash / Net Debt+$300.1MNet Cash Position

Cash vs Debt Ratio

Cash 97%SpringWorks Therapeutics, Inc. cash as % of market cap: 8.70%% · MCap $4BDebt 3%

SpringWorks Therapeutics, Inc. has a net cash position of $300.1M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$308.0M − $7.9M = +$300.1M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

SWTX annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

SWTX cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2024LatestFY$308.0M-35.7%

Dec 31, 2023FY$479.2M-19.1%

Dec 31, 2022FY$592.2M+58.6%

Dec 31, 2021FY$373.5M-26.5%

Dec 31, 2020FY$508.5M+55.2%

SWTX cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

SWTX vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

SpringWorks Therapeutics, Inc.YOU

SWTX

$308.0M$4B8.7%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

SpringWorks Therapeutics, Inc. (SWTX) cash on hand as of December 31, 2024 is $308.0M, comprising $69.8M in cash and cash equivalents (CCE) plus $238.2M in short-term investments — reported as SpringWorks Therapeutics, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as SpringWorks Therapeutics, Inc. cash reserves or cash position.

SpringWorks Therapeutics, Inc. annual cash on hand history shows decreased -35.7% in 2024: decreased -35.7% in 2024. SpringWorks Therapeutics, Inc. cash reserves in 2024 reflect the company's capital allocation strategy.

SpringWorks Therapeutics, Inc. carries total debt of $7.9M against cash of $308.0M, resulting in a net cash position of +$300.1M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

SWTX cash on hand · 5 questions

As of December 31, 2024, SpringWorks Therapeutics, Inc. (SWTX) has $307,985,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $69,751,000 in cash and cash equivalents (CCE) plus $238,234,000 in short-term investments. Latest quarter (March 31, 2025): $287,873,000. Data sourced from the annual 10-K filing via FMP.

SWTX cash on handSWTX cash reservesSWTX cash 2024how much cash does SWTX have

▸ Source: FMP /balance-sheet-statement · US GAAP · SpringWorks Therapeutics, Inc. · SpringWorks Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2024